Concept
Anxiety Treatment
Anxiety treatment studies evaluate clinical and digital interventions that reduce anxiety symptoms and related distress.
Anxiety is among the most common reasons students will see digital and clinic-based mental-health tools.
Evidence
What the evidence shows
Drawn from 3 studies in this library. Each finding starts with a plain-language takeaway, then the denser detail. Supports means evidence for a finding; Challenges means evidence against a stated position; Qualifies marks scope with a short note on each study’s contribution. Challenged positions are labeled — they are not findings.
Multiple studies in this library examine anxiety treatment with empirical patient or population outcomes rather than opinion alone.
- Coaching vs recommendations in IntelliCare
- Automated e-therapy for anxiety disorders
- IntelliCare app suite field trial
Study Role Design N Population Outcome Coaching vs recommendations in IntelliCare Supports RCT2×2 factorial: coaching vs self-guided × weekly app recommendations vs none N=301 · Adults with elevated PHQ-9 or GAD-7 using IntelliCare suite Adults with elevated depression or anxiety symptoms using IntelliCare Android apps PHQ-9/GAD-7 change and app engagement over ~8 weeks Automated e-therapy for anxiety disorders Supports Human experimentOpen-access participant-choice evaluation of five fully automated 12-module programs N=225 · 225 of 2,235 who finished the 12-week treatment window completed posttreatment assessment (10.1%) Adults completing Anxiety Online programs for GAD, panic/agoraphobia, OCD, PTSD, or social anxiety Pre–post symptom change across the five automated anxiety programs IntelliCare app suite field trial Supports Human experimentSingle-arm 8-week field trial of IntelliCare Android suite with low-intensity coaching N=105 · PHQ-9 ≥10 and/or GAD-7 ≥8 at enrollment Adults with elevated depression and/or anxiety symptoms PHQ-9 and GAD-7 change over 8 weeks PHQ-9 and GAD-7 fell significantly over time across arms. Coaching produced larger GAD-7 reductions than self-guided care; recommendations interacted with time to strengthen PHQ-9 gains and raised median app sessions. Engagement was high (median 216 sessions; median last use day 56).
Each program showed a significant multivariate time effect. GAD, OCD, PTSD, and several other program outcomes improved with mostly medium-to-large effects; SAD also improved on most measures. Authors conclude the suite is a promising, accessible treatment pathway for subclinical and clinical anxiety.
Among participants with paired outcomes, PHQ-9 and GAD-7 improved significantly. By end of treatment many met remission or mild-symptom ranges (e.g., 37% PHQ-9 <5; 42% GAD-7 <5). Authors argue modular, eclectic apps can deliver scalable skills-based care.
Open questions
Tensions and limits
Some items are genuine disagreements on the same question. Others mark different assays, populations, or outcomes — limits on how far one study travels — not a forced fight between papers.
Effect sizes and settings differ across anxiety treatment studies — digital vs clinic, trial vs observational — so results should not be pooled casually.
- Coaching vs recommendations in IntelliCare
- Automated e-therapy for anxiety disorders
- IntelliCare app suite field trial
Study Role Design N Population Outcome Coaching vs recommendations in IntelliCare Supports RCT2×2 factorial: coaching vs self-guided × weekly app recommendations vs none N=301 · Adults with elevated PHQ-9 or GAD-7 using IntelliCare suite Adults with elevated depression or anxiety symptoms using IntelliCare Android apps PHQ-9/GAD-7 change and app engagement over ~8 weeks Automated e-therapy for anxiety disorders Supports Human experimentOpen-access participant-choice evaluation of five fully automated 12-module programs N=225 · 225 of 2,235 who finished the 12-week treatment window completed posttreatment assessment (10.1%) Adults completing Anxiety Online programs for GAD, panic/agoraphobia, OCD, PTSD, or social anxiety Pre–post symptom change across the five automated anxiety programs IntelliCare app suite field trial Supports Human experimentSingle-arm 8-week field trial of IntelliCare Android suite with low-intensity coaching N=105 · PHQ-9 ≥10 and/or GAD-7 ≥8 at enrollment Adults with elevated depression and/or anxiety symptoms PHQ-9 and GAD-7 change over 8 weeks
Common misconceptions
Anxiety Treatment findings always generalise to every clinic.
These studies are context-bound; designs, populations, and endpoints limit transfer.
Exam-style questions
Short-answer questions that ask you to explain or compare, not recall.
What is Anxiety Treatment and why do health students study it?
Anxiety treatment studies evaluate clinical and digital interventions that reduce anxiety symptoms and related distress. Anxiety is among the most common reasons students will see digital and clinic-based mental-health tools.
Name one limit of the evidence base for Anxiety Treatment in this library.
Single-setting trials, observational designs, or digital-only samples limit causal and external claims.
The studies
3 studies in this library bear on Anxiety Treatment, ordered by citations.
- IntelliCare app suite field trial
Eight weeks of IntelliCare apps plus light coaching produced large pre–post drops in depression and anxiety symptoms.
- Coaching vs recommendations in IntelliCare
In a factorial RCT, coaching lowered anxiety more than self-guided use, while weekly app recommendations boosted depression improvement and app sessions.
- Automated e-therapy for anxiety disorders
People finishing Anxiety Online’s disorder-specific e-therapy programs showed significant pre–post gains on severity, quality of life, and confidence measures.
Learn alongside
Change log
What changed
Dated edits to this page's evidence: studies added or removed from a claim, claims added or withdrawn, and new explanations tagged here. Rewordings are not listed.
- Concept page published